Feedback on Decentralized Clinical Trials

Written by Barbara Brown

July 19, 2023

The FDA is seeking feedback on its document entitled Decentralized Clinical Trials for Drugs, Biological Products, and Devices Guidance for Industry, Investigators, and Other Stakeholders – this draft Guidance is available at The deadline to submit comments is August 1.

You May Also Like…

Message from N2

Message from N2

The following message is shared together with Karen Arts’s family. With profound sadness, we share the news that Karen...